Ticker brief

NRIX NURIX THERAPEUTICS INC

Consumer, Non-cyclical · Biotechnology

last close
$23.97
1 day
+0.3%
14 days
+36.6%
mkt cap
$2.5B
signals 14d
7
authors 14d
7
Sentiment — last 14 days
daily mean sentiment, 2026-06-25 → 2026-07-01 · now +0.25 (−1 bearish … +1 bullish)
Who spoke7
authorgradetrader scoresignalsmean sent
@HedgeFundTipsB-0.751+0.10
@Brad_E_SchulzC·1+0.20
@SteveDJacobsC-0.201+0.20
@TomLambosC+1.531+0.35
@SandmanMarketsC-2.281+0.45
@FintwitAiC-0.661+0.40
@TautilasC-0.631+0.25
Recent signals7of 7 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-07-01@Tautilas+0.25Watchlist screener for medium-term bullish monthly trend; first six tickers extracted.+0.3%
2026-06-30@FintwitAi+0.40Nurix price target raised to $33 following Roche partnership.-1.2%
2026-06-29@SandmanMarkets+0.45Reports NRIX up almost 50% from prior shared average entry.+0.5%
2026-06-28@TomLambos+0.35Identifies sector rotation into healthcare, software, airlines, homebuilders, retail, and cybersecurity.+4.7%
2026-06-28@SteveDJacobs+0.20Screener lists 13 stocks passing both Qullamaggie and Minervini inspired screens.+4.7%
2026-06-25@Brad_E_Schulz+0.20Sector performance table with gains and ticker lists.+6.7%
2026-06-25@HedgeFundTips+0.10Money-flow list with many tickers; capped first six tickers and mild positive flow implication.+6.7%

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.